Why Is MediciNova ( $MNOV ) Stock Up +29.76% Today? (Find out why any stock moved today on Tickeron.) MNOV shares surged roughly 29.8% intraday, extending a powerful multi-day rally. The primary catalyst was a fresh Buy initiation from Roth/MKM, with a $6.00 price target tied to the company's ALS program. Investors are also positioning ahead of two near-term clinical data readouts: MN-001 in Q3 2026 and the COMBAT-ALS trial of MN-166 by year-end. $FATE $ARDX $CABA $VIR $IMA